Journals / İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası / 2003 / Cilt: 66 - Sayı: 2

Community acquired methiciline resistant Staphylococcus aureus endocarditis: Case report

Toplum kökenli metisiline dirençli Staphylococcus aureus endokarditi: Vaka sunumu

Pages
117–120
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Recently, community-acquired methicillin resistant Staphylococcus aureus infections without any evidence of predisposition from hospital infections were reported.Although multi drug resistance was rare according to hospital-acquired infections, it must be kept in mind in patients with rapidly progressive clinical outcome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Community-Acquired Methicilline Resistant Staphylococcus Aureus Endocarditis: Case Repon Twenty-four years old man admitted to our hospital with fever, headache and somnolance.
📊
Key Findings & Data:Blood sample cultures yielded growth of methicillin resistant Staphylococcus aureus (MRSA) in the second attempt.
💡
Conclusion & Impact:Recently, community-acquired methicillin resistant Staphylococcus aureus infections without any evidence of predisposition from hospital infections were reported.Although multi drug resistance was rare according to hospital-acquired infections, it must be kept in mind in patients with rapidly progressive clinical outcome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Community-Acquired Methicilline Resistant Staphylococcus Aureus Endocarditis: Case Repon Twenty-four years old man admitted to our hospital with fever, headache and somnolance. In the past, he was treated with penicillin every month for rheumatic heart disease secondary prevention. Infective endocarditis was diagnosed with physical and laboratory examinati-on and echocardiography. Intravenous empiric ampicillin-sulbactam, gentamycin and peroral rifampicin were given after blood samples were taken for culture. There were multiple absces-ses and infarcts in cerebrum, cerebellum, bilateral kidneys, spleen and liver seen on computerised tomography. Blood sample cultures yielded growth of methicillin resistant Staphylococcus aureus (MRSA) in the second attempt. Intavenous vancomycin was added to treatment. Recently, community-acquired methicillin resistant Staphylococcus aureus infections without any evidence of predisposition from hospital infections were reported.Although multi drug resistance was rare according to hospital-acquired infections, it must be kept in mind in patients with rapidly progressive clinical outcome.

Özet

Yirmi dört yaşında erkek hasta yüksek ateş, baş ağrısı ve şuur bulanıklığı şikayetleri ile başvurdu. Uzun süredir bilinen romatizmal kalp hastalığı nedeni ile proflaktik aylık penisilin kullanmaktaydı. Fizik muayene, laboratuvar inceleme ve görüntüleme yöntemleri ile infektif endokardit tanısı konuldu. Bilgisayarlı tomografi ile serebrum, serebellum, böbrekler, dalak ve karaciğerde çok sayıda apseler ve infarkt alanları saptandı. Parenteral ampisilin-sulbaktam, gentamisin ve oral rifampisin tedavisi başlandı. Kan kültüründe metisiline dirençli Staphylococcus aureus (MRSA) üredi ve tedaviye parenteral vankomisin eklendi. Son yıllarda hastane infeksiyonları ile ilişkilendirilemeyen toplum kökenli MRSA infeksiyonlarının varlığı ortaya konulmuştur. Çoğul antibiyotik dirençli hastane kökenli infeksiyonlara kıyasla nadir görülse de, ağır seyirli hastalarda direnç sorunu akılda tutulmalıdır. MRSA açısından hiçbir risk faktörü taşımayan bu vaka toplum kökenli MRSA infeksiyonlarına dikkat çekmek için sunulmuştur.

🔖

Cite This Article

ÖZSÜT, H., ÇAĞATAY, Y., SAKA, B. (2022). Community acquired methiciline resistant Staphylococcus aureus endocarditis: Case report. İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası, Cilt: 66 - Sayı: 2, 117–120. https://ajindex.com/articles/553702

References (9)

  1. C Hunt, M Dionne, M Delorme, D Murdock, A Erdrich, MD, et. al. Four Pediatric Deaths from Community-Acquired Methicillin-Resistant Staphylococcus aureus -- Minnesota and North Dakota, 1997-1999. Morbidity and Mortality Weekly Report; 48: 707 (1999)
  2. Cookson B. Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol; 21: 398 (2000)
  3. Embil J, Ramotar K, Romance L, et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies, 1990-1992. Inf Control and Hosp Epid; 15: 646 (1994)
  4. Hackbarth CJ, Chambers HF. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob Agents Chemother; 33: 991 (1989)
  5. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA; 279: 593 (1998)
  6. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother; 44: 1549 (2000)
  7. Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science; 259: 227 (1993)
  8. Lowy F. Staphylococcus aureus infections. N Engl J Med; 339: 520 (1998)
  9. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect; 38: 273 (1998).